Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
Journal of Pediatric Gastroenterology and Nutrition
|
November 8, 2017
Assessment of Liver Disease Progression in Cystic Fibrosis Using Transient Elastography
Anne-Laure Gominon, Eric Frison, Jean-Baptiste Hiriart, et al.
European Journal of Radiology
|
June 3, 2015
MR relaxometry in chronic liver diseases: Comparison of T1 mapping, T2 mapping, and diffusion-weighted imaging for assessing cirrhosis diagnosis and severity
Christophe Cassinotto, Matthieu Feldis, Julien Vergniol, et al.
Radiology
|
May 1, 2013
Liver fibrosis: noninvasive assessment with acoustic radiation force impulse elastography--comparison with FibroScan M and XL probes and FibroTest in patients with chronic liver disease
Christophe Cassinotto, Bruno Lapuyade, Ania Aït-Ali, et al.
Journal of Clinical Gastroenterology
|
July 11, 2017
A Single Test Combining Blood Markers and Elastography is More Accurate Than Other Fibrosis Tests in the Main Causes of Chronic Liver Diseases
Alexandra Ducancelle, Vincent Leroy, Julien Vergniol, et al.
Hepatology (Baltimore, Md.)
|
February 13, 2014
Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C
Julien Vergniol, Jérôme Boursier, Clélia Coutzac, et al.
Clinics and Research in Hepatology and Gastroenterology
|
August 20, 2011
FibroTest and Fibroscan performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate
Thierry Poynard, Victor de Ledinghen, Jean-Pierre Zarski, et al.
Journal of Hepatology
|
September 6, 2011
Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard
Thierry Poynard, Victor de Ledinghen, Jean Pierre Zarski, et al.
Clinics and Research in Hepatology and Gastroenterology
|
September 11, 2012
Performances of Elasto-FibroTest(®), a combination between FibroTest(®) and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis C
Thierry Poynard, Victor de Ledinghen, Jean-Pierre Zarski, et al.
Journal of Medical Virology
|
April 19, 2005
Epidemiological and phylogenetic evidence for patient-to-patient hepatitis C virus transmission during sclerotherapy of varicose veins
Victor de Lédinghen, Pascale Trimoulet, Géraldine Cazajous, et al.
Journal of Hepatology
|
July 13, 2014
Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®)
Thierry Poynard, Julien Vergniol, Yen Ngo, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
Journal of Pediatric Gastroenterology and Nutrition
|
November 8, 2017
Assessment of Liver Disease Progression in Cystic Fibrosis Using Transient Elastography
Anne-Laure Gominon, Eric Frison, Jean-Baptiste Hiriart, et al.
European Journal of Radiology
|
June 3, 2015
MR relaxometry in chronic liver diseases: Comparison of T1 mapping, T2 mapping, and diffusion-weighted imaging for assessing cirrhosis diagnosis and severity
Christophe Cassinotto, Matthieu Feldis, Julien Vergniol, et al.
Radiology
|
May 1, 2013
Liver fibrosis: noninvasive assessment with acoustic radiation force impulse elastography--comparison with FibroScan M and XL probes and FibroTest in patients with chronic liver disease
Christophe Cassinotto, Bruno Lapuyade, Ania Aït-Ali, et al.
Journal of Clinical Gastroenterology
|
July 11, 2017
A Single Test Combining Blood Markers and Elastography is More Accurate Than Other Fibrosis Tests in the Main Causes of Chronic Liver Diseases
Alexandra Ducancelle, Vincent Leroy, Julien Vergniol, et al.
Hepatology (Baltimore, Md.)
|
February 13, 2014
Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C
Julien Vergniol, Jérôme Boursier, Clélia Coutzac, et al.
Clinics and Research in Hepatology and Gastroenterology
|
August 20, 2011
FibroTest and Fibroscan performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate
Thierry Poynard, Victor de Ledinghen, Jean-Pierre Zarski, et al.
Journal of Hepatology
|
September 6, 2011
Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard
Thierry Poynard, Victor de Ledinghen, Jean Pierre Zarski, et al.
Clinics and Research in Hepatology and Gastroenterology
|
September 11, 2012
Performances of Elasto-FibroTest(®), a combination between FibroTest(®) and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis C
Thierry Poynard, Victor de Ledinghen, Jean-Pierre Zarski, et al.
Journal of Medical Virology
|
April 19, 2005
Epidemiological and phylogenetic evidence for patient-to-patient hepatitis C virus transmission during sclerotherapy of varicose veins
Victor de Lédinghen, Pascale Trimoulet, Géraldine Cazajous, et al.
Journal of Hepatology
|
July 13, 2014
Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®)
Thierry Poynard, Julien Vergniol, Yen Ngo, et al.
Page
of 6